378 related articles for article (PubMed ID: 29893470)
1. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
[TBL] [Abstract][Full Text] [Related]
2. Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.
Zhang W; Liu Y; Zhao N; Chen H; Qiao L; Zhao W; Chen JJ
J Virol; 2015 Mar; 89(5):2553-62. PubMed ID: 25520504
[TBL] [Abstract][Full Text] [Related]
3. Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1.
Zhang W; Chen H; Chen Y; Liu J; Wang X; Yu X; Chen JJ; Zhao W
Oncotarget; 2015 Mar; 6(7):5253-62. PubMed ID: 25650660
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
[TBL] [Abstract][Full Text] [Related]
6. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
7. Identification of miRNAs dysregulated in human foreskin keratinocytes (HFKs) expressing the human papillomavirus (HPV) Type 16 E6 and E7 oncoproteins.
Yablonska S; Hoskins EE; Wells SI; Khan SA
Microrna; 2013; 2(1):2-13. PubMed ID: 25070710
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
Jones DL; Münger K
J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
[TBL] [Abstract][Full Text] [Related]
9. Regulator of chromatin condensation 1 abrogates the G1 cell cycle checkpoint via Cdk1 in human papillomavirus E7-expressing epithelium and cervical cancer cells.
Qiao L; Zheng J; Tian Y; Zhang Q; Wang X; Chen JJ; Zhang W
Cell Death Dis; 2018 May; 9(6):583. PubMed ID: 29789527
[TBL] [Abstract][Full Text] [Related]
10. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
[TBL] [Abstract][Full Text] [Related]
11. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
Ruesch MN; Laimins LA
J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
[TBL] [Abstract][Full Text] [Related]
12. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
13. Beta Human Papillomavirus 8E6 Attenuates LATS Phosphorylation after Failed Cytokinesis.
Dacus D; Cotton C; McCallister TX; Wallace NA
J Virol; 2020 Jun; 94(12):. PubMed ID: 32238586
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
[TBL] [Abstract][Full Text] [Related]
16. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
Slebos RJ; Lee MH; Plunkett BS; Kessis TD; Williams BO; Jacks T; Hedrick L; Kastan MB; Cho KR
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5320-4. PubMed ID: 8202487
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6.
McKenna DJ; McDade SS; Patel D; McCance DJ
J Virol; 2010 Oct; 84(20):10644-52. PubMed ID: 20702634
[TBL] [Abstract][Full Text] [Related]
18. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
19. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.
Jones DL; Alani RM; Münger K
Genes Dev; 1997 Aug; 11(16):2101-11. PubMed ID: 9284049
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 E6 and NFX1-123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes.
Levan J; Vliet-Gregg PA; Robinson KL; Katzenellenbogen RA
PLoS One; 2017; 12(11):e0187514. PubMed ID: 29117186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
